Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Review
Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,254 | Dovepress* | 6,318+ | 167 | 6,485 | |
| PubMed Central* | 1,936 | 453 | 2,389 | ||
| Totals | 8,254 | 620 | 8,874 | ||
| *Since 6 October 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 3 | 5 |
View citations on PubMed Central and Google Scholar